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1. introduction 
Mammalian cyclic nucleotide phosphodiesterase 
exists in multiple molecular forms [l] . One of these 
forms depends on a protein activator for full activity 
[2-41 . Recently, the protein activator of cyclic 
nucleotide phosphodiesterase has been purified to 
homogeneity [5-71. Studies from several laboratories 
have established that the enzyme activation has the 
following properties: a) the activation of the enzyme 
by its protein activator requires the presence of Ca2+ 
[6-91, b) the enzyme and the protein activator associate 
to form a protein complex in the presence of Ca2+ 
[lo- 121 and c) the protein activator binds Ca2+ with 
a high affinity [6-81. Based on these observations, 
it has Leen postulated that the free protein exists in 
an inactive conformation which may be converted 
to an active state upon binding of Ca2’. Direct 
evidence in support of a Ca2+ induced conformational 
change in the protein activator has not been reported. 
In the present study, it is shown that Ca2+ exerts a 
significant effect on the stability of the protein acti- 
vator. Especially, the resistance of the protein activator 
to tryptic or chymotryptic attack is greatly enhanced 
by Ca”‘. Concentrations of Ca2+ effective for these 
protections are in the same range as those required 
to show Ca2+ binding to the protein activator. The 
results lend support to the suggested role of Ca2’ in 
the enzyme activation. A preliminary account has been 
presented [ 121. 
2. Materials and methods 
The protein activator and cyclic nucleotide phos- 
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phodiesterase were prepared from bovine heart accord. 
ing to previously established procedures [7] . The 
activity of cyclic nucleotide phosphodiesterase was 
assayed by the procedure of Butcher and Sutherland 
[ 131. One unit of enzyme activity is equivalent to the 
amount of the enzyme which, when maximally 
activated by the protein activator, hydrolyzes 1 pmol 
of CAMP per minute at 30°C. Activity of the protein 
activator was assayed for its ability to stimulate the 
partially purified cyclic nucleotide phosphodiesterase. 
One unit of the activator activity is defined as the 
amount required to activate 0.013 unit of the enzyme 
to 50% of its maximal activation [8]. Low Ca2+ 
reagents and low Ca2+ protein samples were prepared 
according to previously described procedures using 
chelax 100 columns [8] 
3. Results and discussion 
Fig. 1 shows that in solutions containing 10pM Ca2+, 
a low concentration of trypsin has little effect on the 
activity of the protein activator of cyclic nucleotide 
phosphodiesterase. In contrast, in the presence of 0.1 
mM EGTA to chelate the Ca2+ the protein activator is 
rapidly inactivated by trypsin. The protection of the 
protein activator against tryptic inactivation by Ca2’ 
appears specific. The reaction media contained 1 mM 
Mg2+ yet provided no apparent protection in the 
absence of free Ca2+. 
The low level of Ca2+ used in the experiment is not 
expected to affect the activity of trypsin directly. Al- 
though trypsin has been shown to bind Ca2+, there is 
no direct connection between the trypsin activity and 
Ca” binding [ 141 . Thus the result in fig. 1 suggests 
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Fig. 1. Effect of CaZ + and EGTA on the tryptic inactivation of 
the protein activator. The protein activator (100 erg/ml) in a 
pH 7.5 buffer containing 20 mM Tris and 1 mM Mg” was in- 
cubated at 30°C with 1 &ml trypsin in the presence of 
either 10 PM Ca2+ (0) or 0.1 mM EGTA (0). At various 
intervals, aliquots were removed and diluted lo-fold in a 
buffered solution containing 5 pg/ml egg white trypsin 
inhibitor and the activity of the protein activator was measured. 
that the observed Ca2’ effect is due to the binding of 
Ca2+ to the protein activator. Equilibrium binding 
studies [6-81 have revealed the existence of high 
affinity Ca2+ binding sites on the protein activator. 
The initial rate of tryptic inactivation of the 
protein activator in the presence of 0.1 mM EGTA 
follows first order kinetics (fig. 1). Using reagents 
largely freed of contaminating Ca2+, the tryptic 
inactivations of the protein activator at several con 
centrations of Ca2’ have also been found to follow 
first order kinetics. Fig. 2A shows that the plot of 
the decrease in rate of inactivation of the protein 
activator against Ca2’ concentration resembles a 
ligand saturation curve. Double reciprocal plot of the 
data gives a straight line (fig. 2B). The dissociation 
constant calculated from this line is 2.6 PM. Recently, 
we have shown that the protein activator mediated 
Ca2+ activation of cyclic nucleotide phosphodiesterase 
has a Ka value of 2.3 PM for Ca2+. Also, equilibrium 
binding studies have revealed a high affinity Ca2+ 
binding site in the protein activator with a dissociation 
constant in the range of 3-4 W (6-8). The agreement 
between the dissociation constant determined from 
fig. 2B and those obtained previously further sub- 
stantiates the notion that the binding of Ca2+ to the 
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Fig. 2. Effect of Ca*+ concentration on tryptic inactivation 
of the protein activator: Chelax 100 resin purified reagents 
were used in these experiments. Trypsin treatment was 
carried out under conditions similar to those described 
in legend of fig. 1. 
protein activator results in an increased resistance of 
the protein activator to tryptic inactivation. 
A number of enzymes retain their activities after 
limited proteolysis. Thus, the protection of protein 
activator against tryptic inactivation could be due to 
the stabilization by Ca2+ of an active tryptic derivative 
of the protein activator. To test this possibility, 
trypsin treated activator samples have been analyzed 
by polyacrylamide gel electrophoresis. Fig. 3 shows 
that the gel patterns for the samples in 10 MM Ca2+ 
before and after incubation with trypsin are almost 
identical. In contrast, the patterns for the trypsin 
treated sample in 0.1 mM EGTA shows no protein 
material at the position corresponding to that of the 
intact protein activator. The result indicates, therefore 
that the observed effect of Ca2’ on the activity of the 
protein activator results from its protection of the 
protein against tryptic hydrolysis. 
Protection of a protein by its ligand against proteo- 
lysis could be due either to a change in protein confor- 
mation or to the blocking of sensitive peptide bonds 
37.5 
Volume 5 0, number 3 FEBS LETTERS February I975 
Fig. 3. Disc-gel electrophoretic analysis of trypsin-treated 
protein activator: Electrophoresis was carried out on 15% 
polyacrylamide gel at pH 8.3 with a protein activator control 
sample (A) and samples treated with trypsin for 20 min 
in the presence of either 10 PM Ca’+ (B) or 0.1 mM EGTA (C). 
Other conditions of trypsin-treatment are similar to those 
described in legend of fig. 1. 
by the ligand. If the mechanism of the protection is 
the direct blocking of susceptible bonds, inactivation 
of the protein by a second proteolytic enzyme having 
a different specificity would probably not be affected 
by the ligand. Fig. 4 shows that the protein activator 
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Fig. 4. Effect of CaZ’ and EGTA in the chymotryptic in- 
activation of the protein activator. The experimental conditions 
were same as those described in the legend of fig. 1 except 
chymotrypsin and the lima bean protease inhibitor were 
used in place of trypsin and trypsin inhibitor respectively. 
of cyclic nucleotide phosphodiesterase in 0.1 mM EGTA 
is rapidly inactivated by chymotrypsin. Again, 10 PM 
of free Ca*+ completely prevents this inactivation. The 
results, therefore suggest that Ca*+ binding induces a 
conformational change in the protein activator. This 
suggestion is supported by preliminary physical studies. 
Wolfe and Brostrom [7] stated that they had unpub- 
lished results showing a change in circular dichroic 
spectrum of the protein activator upon Ca’+ binding. 
In our laboratory, preliminary results have indicated 
that the fluorescence emission of the protein activator 
is enhanced upon Ca*+ binding [ 121. Presumably, this 
change in proteins conformation enables the protein 
activator to associate with the phosphodiesterase and 
to bring about the enzyme activation. 
Several Ca*+ binding proteins have been identified 
and purified in recent years. Structural studies have 
led to the suggestion that many of these proteins 
are homologous [ 12, 15- 171. Although only a few of 
the Ca*+ binding proteins have identified functional 
roles, many of them have been shown to undergo 
conformational changes upon binding of Ca*+ 
[ 18-201. Possibly a general action pattern of Ca*+ 
binding proteins involves Ca2+- induced conformational 
changes. 
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